These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 445335)
1. Chromosomes and causation of human cancer and leukemia: XXXI. Dq- deletions and their significance in proliferative disorders. Kohno S; Van Den Berghe H; Sandberg AA Cancer; 1979 Apr; 43(4):1350-7. PubMed ID: 445335 [TBL] [Abstract][Full Text] [Related]
2. Marker chromosome 14q + in human cancer and leukemia. Mitelman F Adv Cancer Res; 1981; 34():141-70. PubMed ID: 7025591 [No Abstract] [Full Text] [Related]
3. Longitudinal bone marrow chromosome studies in potential leukemic myeloid disorders. Lisker R; Cobo de Gutiérrez A; Velázquez-Ferrari M Cancer; 1973 Mar; 31(3):509-15. PubMed ID: 4693582 [No Abstract] [Full Text] [Related]
5. Unusual chromosome 7 aberrations in a case of eosinophilic myeloproliferative syndrome. Mitter NS; Weiskopf RW Cancer Genet Cytogenet; 1987 Jun; 26(2):209-12. PubMed ID: 3567874 [TBL] [Abstract][Full Text] [Related]
6. [Cytogenetic study of exudates secondary to hematologic processes]. Bello MJ; Rey JA; Moreno S; Martínez Castro P; Benítez J Sangre (Barc); 1988 Jun; 33(3):165-70. PubMed ID: 3175812 [No Abstract] [Full Text] [Related]
7. Cytogenetic markers in hematoproliferative disorders. Fonatsch C Blut; 1985 Nov; 51(5):315-28. PubMed ID: 3864500 [TBL] [Abstract][Full Text] [Related]
8. Isodicentric (X)(q13): a new characteristic chromosomal anomaly in myeloproliferative syndrome? Petit P; Fryns JP; Masure R; Van Den Berghe H Cancer Genet Cytogenet; 1982 Dec; 7(4):339-41. PubMed ID: 7165869 [No Abstract] [Full Text] [Related]
9. The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study. Yi S; Li H; Li Z; Xiong W; Liu H; Liu W; Lv R; Yu Z; Zou D; Xu Y; An G; Qiu L Int J Hematol; 2017 Sep; 106(3):418-425. PubMed ID: 28439775 [TBL] [Abstract][Full Text] [Related]
11. Clustering of aberrations to specific chromosomes in human neoplasms. III. Incidence and geographic distribution of chromosome aberrations in 856 cases. Mitelman F; Levan G Hereditas; 1978; 89(2):207-32. PubMed ID: 730541 [No Abstract] [Full Text] [Related]
15. [Cytogenetic studies of spleen cells in some myeloproliferative syndromes]. Maj S; Pawelski S Acta Haematol Pol; 1971; 2(1):47-53. PubMed ID: 5293227 [No Abstract] [Full Text] [Related]
16. [Cytogenetics and hematology]. Prieto F; Badía L Med Clin (Barc); 1983 Sep; 81(8):355-61. PubMed ID: 6358717 [No Abstract] [Full Text] [Related]
17. Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review. Panani AD; Pappa V; Papageorgiou S; Stamatelli F; Raptis SA Ann Hematol; 2004 Mar; 83(3):153-5. PubMed ID: 15064863 [TBL] [Abstract][Full Text] [Related]
18. [Letter: Homozygosity for 1 chromosome in a patient with a myeloproliferative syndrome]. Berger R; Brière J; Clauvel JP Nouv Presse Med; 1976 Mar; 5(10):652. PubMed ID: 1264596 [No Abstract] [Full Text] [Related]
19. Chromosomes and causation of human cancer and leukemia. LI. A hairy cell leukemia case with 14q+ and ring chromosomes: significance of ring chromosomes in blood disorders. Sadamori N; Han T; Kakati S; Sandberg AA Cancer Genet Cytogenet; 1983 Sep; 10(1):67-77. PubMed ID: 6883301 [TBL] [Abstract][Full Text] [Related]
20. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders. Werner M; Nolte M; Kaloutsi V; Buhr T; Kausche F; Georgii A Lab Invest; 1995 Apr; 72(4):405-10. PubMed ID: 7723278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]